1. Home
  2. MITQ vs ITOC Comparison

MITQ vs ITOC Comparison

Compare MITQ & ITOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moving iMage Technologies Inc.

MITQ

Moving iMage Technologies Inc.

HOLD

Current Price

$0.58

Market Cap

5.9M

ML Signal

HOLD

ITOC

iTonic Holdings Ltd Class A Ordinary Shares

N/A

Current Price

$0.35

Market Cap

7.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MITQ
ITOC
Founded
N/A
1998
Country
United States
China
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
7.0M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
MITQ
ITOC
Price
$0.58
$0.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
481.0K
419.5K
Earning Date
05-15-2026
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$20,139,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$63.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.42
$0.25
52 Week High
$1.66
$0.65

Technical Indicators

Market Signals
Indicator
MITQ
ITOC
Relative Strength Index (RSI) 46.41 52.07
Support Level $0.49 $0.29
Resistance Level $0.64 $0.36
Average True Range (ATR) 0.08 0.04
MACD 0.00 0.01
Stochastic Oscillator 21.45 47.55

Price Performance

Historical Comparison
MITQ
ITOC

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

About ITOC iTonic Holdings Ltd Class A Ordinary Shares

iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors.

Share on Social Networks: